We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant

25 hedge funds and large institutions have $5.77M invested in TriSalus Life Sciences Warrant in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less capital invested

Capital invested by funds: $6.13M → $5.77M (-$365K)

7% less funds holding

Funds holding: 2725 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
5
Closed
5
Calls
$583K
Puts
Net Calls
+$583K
Net Calls Change
+$447K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.37M
AGC
2
Angelo Gordon & Co
New York
$951K
BlackRock
3
BlackRock
New York
$753K
MF
4
Magnetar Financial
Illinois
$471K +$533K +573,947 New
PWAM
5
Park West Asset Management
California
$342K
AC
6
Aristeia Capital
Connecticut
$321K
DM
7
Deerfield Management
New York
$273K +$309K +333,333 New
LA
8
Linden Advisors
New York
$205K
SCC
9
Spring Creek Capital
Kansas
$137K
PAMP
10
Polar Asset Management Partners
Ontario, Canada
$123K
VI
11
Vestcor Inc
New Brunswick, Canada
$122K
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$109K
MA
13
MYDA Advisors
New York
$98K -$186 -200 -0.2%
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
$78K
CH
15
CVI Holdings
Delaware
$68K
SCM
16
Shaolin Capital Management
Florida
$63K -$2.78K -3,000 -4%
CCM
17
Context Capital Management
California
$58K
UOC
18
UBS O'Connor
Illinois
$56K
AA
19
AQR Arbitrage
Connecticut
$55K
MS
20
Maven Securities
Jersey
$42K +$15.5K +16,666 +48%
KJHP
21
K.J. Harrison & Partners
Ontario, Canada
$39K -$27.8K -30,000 -39%
Jane Street
22
Jane Street
New York
$14K -$587 -633 -4%
OCAM
23
Owl Creek Asset Management
New York
$11K
UBS Group
24
UBS Group
Switzerland
$5K +$5.57K +6,006 New
GCL
25
Glazer Capital LLC
New York
$1K -$16.1K -17,396 -96%

TLSIW Hedge Fund Activity: Q3 2021 in Review

25 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2021, worth a combined $5.77M — down 6% from $6.13M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TLSIW and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 1 added.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $533K. The largest seller was PEAK6 Investments, exiting entirely with an estimated $245K sold.

  • 25 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2021, down from 27 in Q2 2021.
  • Funds reported $5.77M of TriSalus Life Sciences Warrant stock for Q3 2021, down 6% quarter-over-quarter.
  • 3 funds opened new TriSalus Life Sciences Warrant positions in Q3 2021 and 5 closed out, a net change of -2 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q3 2021 was Magnetar Financial, an estimated $533K added.
  • The largest TriSalus Life Sciences Warrant seller in Q3 2021 was PEAK6 Investments, an estimated $245K sold.

Based on aggregated 13F filings for Q3 2021.